Stay ahead of the market with Aura AI
PDD Holdings set to report Q2 earnings with mixed analyst outlook and strong financial health.
PDD Holdings Inc. will report its Q2 2026 earnings on August 24, with expected EPS of $2.72 and revenue around $16.94 billion. Despite recent stock gains, analysts have mixed views, including an Underperform rating from BNP Paribas and a downgrade by...
JD Sports cuts profit forecast after weak sales, shares drop nearly 15%.
JD Sports Fashion reported weaker-than-expected second-quarter sales, especially in North America, prompting a cut in its full-year profit guidance. This led to a nearly 15% drop in its stock price. Analysts from Citigroup, UBS, and Shore Capital mai...
Jones Lang LaSalle sees insider sale but strong institutional buying and bullish golden cross signal.
Jones Lang LaSalle's CEO sold 2,000 shares worth over $773,000, yet major investors like BlackRock increased holdings significantly, showing confidence. BlackRock now owns over 10% of the company after a $1.45 billion stake purchase. Other firms also...
Wedbush raises Scholar Rock price target to $64 ahead of FDA decision on SMA drug.
Wedbush increased its price target for Scholar Rock to $64 from $58 and kept an "Outperform" rating ahead of the FDA's September 30 decision on Scholar Rock's investigational SMA drug, apitegromab. This drug could be the first muscle-targeted therapy...
IM Cannabis to execute 1-for-30 reverse stock split to meet Nasdaq's $1 minimum share price
IM Cannabis Corp., a medical cannabis company operating in Israel and Germany, will conduct a 1-for-30 reverse stock split on August 27, 2026. This move aims to increase its share price, currently at $0.11, to meet the Nasdaq Capital Market's minimum...
Buckle posts strong Q2 with EPS $0.87 and revenue $319.82M, beating estimates despite slight net income dip.
Buckle, Inc. reported strong Q2 earnings with an EPS of $0.87, surpassing analyst estimates of $0.81, and revenue of $319.82 million, slightly above expectations. The company saw a 4.6% increase in net sales, driven by growth in both comparable-store...
Institutions boost Ethereum confidence by leveraging Coinbase staking services.
Institutional investors are increasingly using Coinbase's staking services to earn rewards and secure assets on proof-of-stake networks like Ethereum and Solana. This trend signals growing institutional confidence in Ethereum's long-term potential an...
Rapport Therapeutics' RAP-219 shows promise with long half-life and strong funding through Phase 3 trials.
Rapport Therapeutics stands out for its drug RAP-219, which has a unique neuroanatomical selectivity and a long 22-day half-life, potentially offering advantages in treatment adherence. The company is well-funded with $436.1 million in cash, expected...
Ripple's RLUSD stablecoin market cap tops $2B, closing in on PayPal USD's $2.87B valuation.
Ripple's RLUSD stablecoin has surpassed a $2 billion market capitalization, rapidly approaching PayPal USD's $2.87 billion. Launched in December 2024, RLUSD is one of the fastest-growing regulated stablecoins, with significant minting activity boosti...
Helus Pharma advances psychedelic treatments for depression and anxiety with promising early trial data.
Helus Pharma is developing psychedelic drugs, including oral psilocin and intramuscular DMT, targeting major depressive disorder (MDD) and generalized anxiety disorder (GAD). Early clinical trials show promising efficacy and durability as adjunctive ...
